本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

8.26
+0.05000.61%
盘后8.16-0.1000-1.21%16:08 EDT
成交量:76.13万
成交额:628.94万
市值:11.29亿
市盈率:206.50
高:8.34
开:8.19
低:8.14
收:8.21
数据加载中...
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]